Compare FGEN & CRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FGEN | CRT |
|---|---|---|
| Founded | 1993 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.6M | 42.5M |
| IPO Year | 2014 | 1992 |
| Metric | FGEN | CRT |
|---|---|---|
| Price | $8.55 | $8.04 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $146.50 | N/A |
| AVG Volume (30 Days) | ★ 39.5K | 26.2K |
| Earning Date | 11-10-2025 | 03-12-2026 |
| Dividend Yield | N/A | ★ 9.49% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 53.38 | 0.74 |
| Revenue | ★ $8,298,000.00 | $5,621,913.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $0.17 | $10.64 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.85 | $7.07 |
| 52 Week High | $21.94 | $13.31 |
| Indicator | FGEN | CRT |
|---|---|---|
| Relative Strength Index (RSI) | 48.67 | 46.89 |
| Support Level | $8.30 | $7.34 |
| Resistance Level | $10.47 | $8.27 |
| Average True Range (ATR) | 0.61 | 0.32 |
| MACD | 0.06 | -0.03 |
| Stochastic Oscillator | 22.58 | 53.45 |
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.
Cross Timbers Royalty Trust is a United States-based trust. The net profits interests are derived from producing royalty, overriding royalty interests, and working interest properties. The underlying properties of the trust include producing properties in Texas, Oklahoma, and New Mexico.